1.57
price up icon4.67%   0.07
after-market After Hours: 1.68 0.11 +7.01%
loading

Iterum Therapeutics Plc Stock (ITRM) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
46.09%
6.163
11.43 16.68 10.82 8.53
Operating Income/Loss
46.09%
-6.163
-11.43 -16.68 -10.82 -8.53
Nonoperating Income/Loss
12.80%
-0.89
-0.789 12.97 -1.234 -1.236
Income/Loss From Continuing Operations Before Tax
42.28%
-7.053
-12.22 -3.716 -12.06 -9.766
Income Tax Expense/Benefit
66.20%
0.048
0.142 0.161 0.187 0.123
Income/Loss From Continuing Operations After Tax
42.56%
-7.101
-12.36 -3.877 -12.24 -9.889
Net Income/Loss
42.56%
-7.101
-12.36 -3.877 -12.24 -9.889
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
20,899%
15.43
0.0735 13.04 12.94 12.68
Diluted Average Shares
20,899%
15.43
0.0735 13.04 12.94 12.68
Basic Earnings Per Share
51.06%
-0.46
-0.94 -0.30 -0.95 -0.78
Diluted Earnings Per Share
51.06%
-0.46
-0.94 -0.30 -0.95 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):